Business Wire

Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment

FOSTER CITY, Calif., & RAHWAY, N.J.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the primary ...
Business Wire

Calibr-Skaggs Advances CLF065, a Regenerative GLP-2 Therapy, into Two Phase 2 IBD Studies

CLF065, a long-acting, once-weekly GLP-2 receptor agonist, advances in two inflammatory bowel disease indications. The studies aim to bring a regenerative treatment option to patients living with IBD, ...
The Verge

You can just tell the Instagram algorithm what you want now

Adam Mosseri wants AI to give users a sense of control over recommendations. Adam Mosseri wants AI to give users a sense of control over recommendations. is a senior reporter covering technology, ...
Le Lézard

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

AbbVie today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of upadacitinib (RINVOQ®; 15 ...
Hosted on MSN

Disney adds two new MCU movies to Phase 7

As Marvel Studios continues to move forward in its 2026 slate, the franchise shows no signs of slowing down before the end of Phase 6. The release of Spider-Man: Brand New Day's first trailer gave ...